期刊文献+

国内外医药企业技术创新发展及研究方法综述 被引量:6

国内外医药企业技术创新发展及研究方法综述
下载PDF
导出
摘要 目的:本文对于进一步的医药企业技术创新发展研究以及政府有效政策的制定具有指导性的意义。方法:本文在阐述医药企业技术创新特征的基础上,分成三个部分深入研究了国内外医药企业技术创新的概况:一为国内外医药企业技术创新的发展背景;二为医药企业技术创新能力的内涵界定;三为国内外医药企业技术创新的研究方法归纳。综上所述,最后基于技术创新提出医药企业的发展战略和趋势。结论:当今世界医药制造业的发展,技术创新是其主要的驱动力量,我国有关部门应找到医药企业技术创新突破点,促进医药产业的转型升级。 Objective:The study is presented guiding significance for further research of technological innovation in pharmaceutical firms and effective government policy setting.METHODS:This paper is based on the characteristics of technological innovation in pharmaceutical firms,and then it is divided into three parts for a depth-study of technological innovation in the domestic and foreign pharmaceutical firms:first,the development background of technological innovation for domestic and foreign pharmaceutical firms;Second,the definition of technological innovation for pharmaceutical firms;Third,the induction of research methods for technological innovation in domestic and foreign firms.To sum up,lastly the paper is based on technological innovation and offers strategy and development trends for pharmaceutical firms.CONCLUSION:The development of the world pharmaceutical industry,technological innovation is the main driving force,the relevant departments should find a breakthrough of pharmaceutical technology innovation and promote the transformation and upgrading of the pharmaceutical industry.
出处 《现代物业(中旬刊)》 2010年第8期9-13,共5页 Modern Property Management
关键词 医药企业 技术创新 医药技术 Pharmaceutical firms Technological innovation Pharmaceutical technology
  • 相关文献

参考文献10

  • 1SCHUMPETER.Theory of Economic Development[]..1997
  • 2SCHOENECKER T,SWANSON L.Indicators of firm technological capability:validit91y and performance implications[].I EEE Transacions on Engineering Management.2002
  • 3GREGORY N.STOCK,NOEL P.GREIS,WILLIAM A.FISCHER.Firm size and dynamic technological innovation[].Technovation.2002
  • 4WANG W G.The Research on the Growth Features and Mechanisms of China’s Medical Industry[]..2007
  • 5GAUTIER DUFLOS.Persistence of Innovation,Technological Change and Quality-Adjusted Patents in the US Pharmaceutical Industry. CNRS 2006-29 .
  • 6LYNNE G.ZUCKER,MICHAEL R.DARBY.Present at the biotechnological revolution:transformation of technological identity for a large incumbent pharmaceutical firm[].Research Policy.1999
  • 7YOSHIKAWA,A.The other drug war:U.S.-Japan trade in pharmaceuticals[].CalifManageRevReprint Ser.1989
  • 8ALEXANDER.Creative marketing and innovative consumer product design-some case studies[].Design Studies.1985
  • 9ALKA CHADHA.Product Cycles,Innovation,and Exports:A Study of Indian Pharmaceuticals[].World Development.2009
  • 10QIN X.The R&D empirical test of the chinese listed medical companies[]..2007

同被引文献29

引证文献6

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部